Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Brescia
Clinical trial register · Italy

Clinical Trials in Brescia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca27 Fondazione Italiana Linfomi - ETS25 Novartis Pharmaceuticals21 Hoffmann-La Roche18 Merck Sharp & Dohme LLC16
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Brescia

522 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Alessandria, Bologna, Brescia, Cremona, Genova, Legnago, Milan, Naples
2017-05-03
Recruiting
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Observational
20
Brescia
2017-02-09
Active, closed
Acerta Pharma BV
Phase 3
310
Aviano, Bergamo, Brescia, Florence, Genova, Meldola, Milan, Modena
2017-02-02
Active, closed
ViiV Healthcare
Phase 3
618
Brescia, Milan
2016-10-28
Active, closed
ViiV Healthcare
Phase 3
631
Brescia, Milan, Monza MB, Roma
2016-10-27
Recruiting
UMC Utrecht
Phase 3
20,000
Brescia, Milan, Palermo, Reggio Emilia, Rimini
2016-04-11
Active, closed
Novartis Pharmaceuticals
Phase 4
233
Bergamo, Bologna, Brescia, Meldola, Monza, Milan, Rozzano, Modena
2015-12-11
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Bologna, Brescia, Milan, Monza
2015-07-14
Active, closed
Medtronic
Observational
3,100
Bari, Bologna, Brescia, Cotignola, Milan, Pisa, Roma
2015-07
Active, closed
Acerta Pharma BV
Phase 3
535
Alessandria, Aviano, Brescia, Florence, Meldola, Milan, Parma, Ravenna
2015-06-26
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Ancona, Bari, Bologna, Brescia, San Giovanni Rotondo, Florence, Milan, Rozzano
2015-03-05
Active, closed
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
NCT01934725Brain Infarction, Ischemic Stroke, Thrombosis, Foramen Ovale, Patent
SECRETO Study Consortium
Observational
1,200
Brescia, Reggio Emilia
2013-11
Active, closed
Washington University School of Medicine
Phase 2/3
490
Brescia, Florence
2012-12
Active, closed
Sentinel Node Vs Observation After Axillary Ultra-souND
NCT02167490Early Stage Breast Carcinoma
European Institute of Oncology
Not applicable
1,560
Bolzano, Brescia, Cagliari, Castellanza, Como, Mantua, Milan, Naples
2012-01
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Acquaviva delle Fonti, Ancona, Bari, Bologna, Brescia, Caserta, Castrovillari, Cotignola
2012-01
Recruiting
Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
NCT06911099Atrial Functional Mitral Regurgitation, Mitral Insufficiency
University Hospital of Cologne
Observational
1,000
Brescia, Milan, Pisa
2010-01-01
Recruiting
Global Registry and Natural History Study for Mitochondrial Disorders
NCT05554835Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD, SANDO
LMU Klinikum
Observational
6,000
Bologna, Brescia, Cagliari, Florence, Genova, Messina, Milan, Pisa
2009-02-01
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Ancona, Bolzano, Brescia, Florence, Genova, Naples, Parma, Province of Macerata
2008-12-09
Recruiting
Pompe Pregnancy Sub-Registry
NCT00567073Glycogen Storage Disease Type II (GSD-II), Pompe Disease (Late-onset), Glycogenesis 2 Acid Maltase Deficiency
Genzyme, a Sanofi Company
Observational
20
Florence, Milan, Padua, Rome, Brescia, Cagliari, Genova, Messina
2007-06-18
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Gussago, Cona, Florence, Milan, Padua, Rome, Brescia, Cagliari
2004-09-15
Recruiting
Manuel Monreal
Observational
120,000
Avezzano, Belluno, Brescia, Avellino, Naples, Marcianise, Castelfranco, Cremona
2001-03
Recruiting
Medtronic
Observational
20,000
Ancona, Bari, Bologna, Brescia, Castrovillari, Cotignola, Lecce, Milan
1983-01
Rows per page Showing 501–522 of 522
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 October 2026. https://priyalifescience.com/clinical-trials-italy/city/brescia?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 522 of those studies with a site in Brescia.

How many clinical trials are recruiting in Brescia?

291 of the 522 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 21 have not yet opened recruitment, 209 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.